Reduced antiviral gene expression and elevated CXCL8 expression in peripheral blood are associated with severe hypoxemia in RSV-infected children
The pathology of respiratory syncytial virus (RSV) infection remains unclear. An unbalanced immune response to RSV infection can lead to immunopathology, causing airway damage and impaired exchange of oxygen and carbon dioxide between the air and the bloodstream. We aimed to evaluate the association of the expression of inflammatory and antiviral genes in peripheral blood with severe hypoxemia in children with RSV infection seen in the hospital emergency room. We conducted a cross-sectional study on 121 RSV-infected children seen in hospital emergency rooms between 2015 and 2023. Total RNA was extracted from whole blood samples, and gene expression (<i>IL-6</i>, <i>TNFα</i>, <i>CXCL8</i>, <i>ISG15</i>, <i>IFIT1</i>, <i>RIGI</i>, <i>IFNβ</i>, <i>CCL5</i>, and <i>CXCL10</i>) was quantified using quantitative RT-PCR. The outcome variable was having severe hypoxemia (SpO<sub>2</sub> ≤ 90%). The association analysis was performed using a volcano plot, adjusted logistic regression, and orthogonal partial least squares discriminant analysis (OPLS-DA). We found that 26 of 121 children had severe hypoxemia (SpO<sub>2</sub> ≤ 90%). <i>CXCL8</i> was overexpressed [fold changes (FC) > 2; <i>q</i>-value < 0.05], and <i>ISG15</i>, <i>IFIT1</i>, <i>RIGI</i>, <i>IFNβ</i>, <i>CCL5</i>, and <i>CXCL10</i> were underexpressed (FC <0.5; <i>q</i>-value <0.05) in children with severe hypoxemia. These associations were ratified using adjusted logistic regression. The OPLS-DA showed that the gene expressions of <i>CXCL8</i>, <i>ISG15</i>, <i>IFIT1</i>, <i>RIGI</i>, and <i>CXCL10</i> had values of variable importance in projection (VIP) ≥1, being the most relevant features. In conclusion, an imbalance favoring inflammation over antiviral defense may contribute to the pathogenesis of severe hypoxemia in RSV-infected children. These findings provide valuable insights into the pathology of RSV infection.
Authors
- Ana Virseda‐Berdices (ORCID: https://orcid.org/0000-0002-9549-567X)
- Salvador Resino (ORCID: https://orcid.org/0000-0001-8783-0450)
- Vanesa Matías del Pozo (ORCID: https://orcid.org/0000-0003-0171-2184)
- Isidoro Martínez (ORCID: https://orcid.org/0000-0002-9949-9264)
- María Dolores Rodríguez Mesa (ORCID: https://orcid.org/0000-0002-3382-0465)
- Alejandro González‐Praetorius (ORCID: https://orcid.org/0000-0002-7886-0321)
- Carlos Pita-Martínez
- Carmen Goez-Sanz (ORCID: https://orcid.org/0000-0003-3501-2143)
- Esther Mazario-Martín (ORCID: https://orcid.org/0009-0000-7763-304X)
- Marta Quero‐Delgado (ORCID: https://orcid.org/0009-0003-8097-0137)
Institutions
- Universidad de Valladolid (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario de Guadalajara (ES)
- Centro Nacional de Microbiologia (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínico Universitario de Valladolid (ES)
- Hospital Universitario Infanta Cristina (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3389/fimmu.2024.1438630
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Instituto de Salud Carlos III